Stay updated on Nivolumab for Uterine Cancer - Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Uterine Cancer - Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Uterine Cancer - Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page's revision label has been updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T00:24:42.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed earlier notices including Revision: v3.4.1 and the government funding status notice with links to operating status.
    Difference
    0.4%
    Check dated 2026-02-11T11:00:05.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Notice about government funding lapse and NIH Clinical Center operating status added; revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:20:38.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated QC/versioning labels: 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while removing the older forms 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:16:57.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision tag updated to v3.3.4, replacing v3.3.3. This is a minor site maintenance change and does not alter the study details, eligibility criteria, or user actions on the page.
    Difference
    0.1%
    Check dated 2026-01-14T01:54:47.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Added a new Locations section listing trial sites by state (New Jersey, New York, Pennsylvania). Removed the HHS Vulnerability Disclosure link from the footer.
    Difference
    0.4%
    Check dated 2025-12-23T17:25:18.000Z thumbnail image

Stay in the know with updates to Nivolumab for Uterine Cancer - Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Uterine Cancer - Clinical Trial page.